Previously doing business as Gene Security Network, Natera, Inc. is a genetic testing company designing targeted assays to analyze tiny quantities of DNA: elevating the science and utility of prenatal testing. Fairly SBIR active in the arly years, but now longtime having outgrown SBIR eligibility, the defined mission of the company is to help families diagnose and manage genetic disease. In pursuit of that mission, Natera operates a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California, currently offering a host of preconception and prenatal genetic testing services primarily to OBGYN physicians and in-vitro fertilization centers. In 2013, the company launched Panorama, a safe, simple test for pregnant women that screens for the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Tests developed by Natera have not been cleared or approved by the U.S. Food and Drug Administration (FDA). Natera was honored in 2014 to be selected to attend and participate in the famous, highly exclusive Davos World Economic Forum.
